Clinical trial / 2009
Pomegranate juice consumption for up to 18 months did not significantly alter overall carotid intima-media thickness progression rate in moderate-risk adults.
This randomized, double-blind, parallel trial evaluated the effect of consuming 240 ml/day of pomegranate juice (n = 146) versus a control beverage (n = 143) for up to 18 months in adults at moderate risk for coronary heart disease. No significant difference in overall CIMT progression rate was observed between pomegranate juice and control treatments. In exploratory analyses, participants in the most adverse tertiles for baseline lipid peroxides, triglycerides, HDL cholesterol, triglyceride/HDL ratio, total cholesterol/HDL ratio, and apolipoprotein-B100 who drank pomegranate juice had significantly less anterior wall and/or composite CIMT progression compared with controls.
- Study type
- Randomized, double-blind, parallel trial
- Who was studied
- 289 men (45-74 y) and women (55-74 y) at moderate risk for coronary heart disease
- What was measured
- Anterior and posterior carotid intima-media thickness (CIMT) progression rates
THE PAPER
Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease.
Davidson MH, Maki KC, Dicklin MR, Feinstein SB, Witchger M, Bell M, McGuire DK, Provost JC, Liker H, Aviram M. Am J Cardiol, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.